{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06388083",
            "orgStudyIdInfo": {
                "id": "LBS-008-CT07"
            },
            "organization": {
                "fullName": "Belite Bio, Inc",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease",
            "officialTitle": "A Phase 1b Open-label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Tinlarebant in Japanese Subjects With Stargardt Disease and a Phase 2/3 Randomized, Double-masked, and Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Tinlarebant in Subjects With Stargardt Disease",
            "acronym": "DRAGON II",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-phase-study-to-evaluate-the-efficacy-and-safety-of-tinlarebant-in-subjects-with-stargardt-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07-30",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-04-23",
            "studyFirstSubmitQcDate": "2024-04-26",
            "studyFirstPostDateStruct": {
                "date": "2024-04-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-03",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Belite Bio, Inc",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of tinlarebant in subjects with Stargardt Disease",
            "detailedDescription": "This study will be comprised of a Phase 1b part conducted in Japan and a Phase 2/3 part. The Phase 1b part of the study will be open-label and will evaluate the pharmacokinetics (PK), pharmacodynamics (PD), safety, and tolerability of daily doses of 5 mg tinlarebant, administered for 7 days, in Japanese subjects with Stargardt Disease (STGD1). The Phase 2/3 part of the study will be randomized, double masked, and placebo controlled to evaluate the safety, tolerability, and efficacy of daily doses of 5 mg tinlarebant, administered for 24 months, in subjects with STGD1."
        },
        "conditionsModule": {
            "conditions": [
                "STGD1",
                "Stargardt Disease 1"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2",
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "LBS-008, Tinlarebant",
                    "type": "EXPERIMENTAL",
                    "description": "5 mg tablet taken orally once a day",
                    "interventionNames": [
                        "Drug: Tinlarebant"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo tablets for tinlarebant 5 mg prepared similarly",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Tinlarebant",
                    "description": "5 mg tablet",
                    "armGroupLabels": [
                        "LBS-008, Tinlarebant"
                    ],
                    "otherNames": [
                        "LBS-008"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo tablets",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "To measure the annualized rate of change from baseline lesion size in aggregate area of atrophy",
                    "timeFrame": "From baseline to Month 24"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "To measure the annualized rate of change in total area of atrophy",
                    "timeFrame": "From baseline to Month 24"
                },
                {
                    "measure": "Change in BCVA measured by the ETDRS method",
                    "timeFrame": "From baseline to Month 24"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Subjects must have clinically diagnosed STGD1 with at least one mutation identified in the ABCA4 gene.\n* Subjects must have a defined aggregate atrophic lesion in 1 or both eyes.\n* Minimum BCVA is required in the study eye\n\nExclusion Criteria:\n\n* Any ocular disease other than STGD1 that, in the opinion of the investigator, would complicate assessment of a treatment effect.\n* History of ocular surgery in the study eye in the last 3 months.\n* Any prior gene therapy.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "12 Years",
            "maximumAge": "20 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Belite Bio Clinical Operations",
                    "role": "CONTACT",
                    "phone": "+886 972 080 097",
                    "email": "clinicaltrial@belitebio.com"
                }
            ],
            "locations": [
                {
                    "facility": "Belite Study Site",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92037",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Belite Study Site",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75231",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Belite Study Site",
                    "city": "Kyoto",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.02107,
                        "lon": 135.75385
                    }
                },
                {
                    "facility": "Belite Study Site",
                    "city": "Tokyo",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.6895,
                        "lon": 139.69171
                    }
                },
                {
                    "facility": "Bellite Study Site",
                    "city": "London",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000080362",
                    "term": "Stargardt Disease"
                },
                {
                    "id": "D000008268",
                    "term": "Macular Degeneration"
                }
            ],
            "ancestors": [
                {
                    "id": "D000015785",
                    "term": "Eye Diseases, Hereditary"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                },
                {
                    "id": "D000012162",
                    "term": "Retinal Degeneration"
                },
                {
                    "id": "D000012164",
                    "term": "Retinal Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M2147",
                    "name": "Stargardt Disease",
                    "asFound": "Stargardt Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11260",
                    "name": "Macular Degeneration",
                    "asFound": "Stargardt Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18339",
                    "name": "Eye Diseases, Hereditary",
                    "relevance": "LOW"
                },
                {
                    "id": "M14997",
                    "name": "Retinal Degeneration",
                    "relevance": "LOW"
                },
                {
                    "id": "M14999",
                    "name": "Retinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "T5470",
                    "name": "Stargardt Disease",
                    "asFound": "Stargardt Disease",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}